<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">Inflammatory bowel disease</z:e> (IBD), which comprises <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> and <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo>, is characterized by <z:mp ids='MP_0001845'>inflammation</z:mp> of the gastrointestinal tract </plain></SENT>
<SENT sid="1" pm="."><plain>The trefoil factors 1, 2, and 3 (TFF1-3) are a family of <z:chebi fb="7" ids="16670">peptides</z:chebi> that play important roles in the protection and repair of epithelial surfaces, including the gastrointestinal tract </plain></SENT>
<SENT sid="2" pm="."><plain>TFFs may be involved in IBD pathogenesis and are a potential treatment option </plain></SENT>
<SENT sid="3" pm="."><plain>In the present review, we describe the TFF family and their potential role in IBD by summarizing the current knowledge of their expression, possible function and pharmacological role in IBD </plain></SENT>
</text></document>